Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00538369 · ClinicalTrials.gov registry record · Phase 4
Combining Observational and Physiologic Sedation Assessment Tools
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 67
- Enrollment target
NCT00538369 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 67 participants.
The verdict
NCT00538369, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 67 participants
- Enrollment target
Study Summary
When a physiologic tool to measure the patient's hypnotic state is added to current practice tools is there a decrease in the amount of drug the patient receives.
Interventions
- DEVICE Bispectral index monitor
- OTHER Ramsay Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00538369
The ClinicalTrials.gov registry entry for NCT00538369 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bispectral index monitor is the first listed.
NCT00538369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00538369 about?
NCT00538369 is a clinical study titled "Combining Observational and Physiologic Sedation Assessment Tools". When a physiologic tool to measure the patient's hypnotic state is added to current practice tools is there a decrease in the amount of drug the patient receives.
What is the current status of trial NCT00538369?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 67 participants. The study started on 2006-11. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00538369?
The interventions under investigation include: Bispectral index monitor (DEVICE), Ramsay Scale (OTHER).
Who is sponsoring clinical trial NCT00538369?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.